{"organizations": [], "uuid": "f4b8a5c6814aa0a44d840e50c2ae2df1ecfab111", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s2.reutersmedia.net/resources/r/?m=02&d=20180327&t=2&i=1245310293&w=1200&r=LYNXMPEE2Q0WE", "site_section": "http://www.reuters.com/resources/archive/us/20180327.html", "section_title": "Archive News &amp; Video for Tuesday, 27 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/us-akorn-lawsuit-fresenius/fresenius-spokesman-says-probe-into-target-akorn-continues-idUSKBN1H31HX", "country": "US", "domain_rank": 408, "title": "Fresenius spokesman says probe into target Akorn continues", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.223, "site_type": "news", "published": "2018-03-27T19:43:00.000+03:00", "replies_count": 0, "uuid": "f4b8a5c6814aa0a44d840e50c2ae2df1ecfab111"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/us-akorn-lawsuit-fresenius/fresenius-spokesman-says-probe-into-target-akorn-continues-idUSKBN1H31HX", "ord_in_thread": 0, "title": "Fresenius spokesman says probe into target Akorn continues", "locations": [], "entities": {"persons": [{"name": "arno schuetze", "sentiment": "none"}, {"name": "reuters/ralph orlowski", "sentiment": "none"}], "locations": [{"name": "frankfurt", "sentiment": "none"}, {"name": "bad homburg", "sentiment": "none"}, {"name": "frankfurt", "sentiment": "none"}, {"name": "germany", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "akorn", "sentiment": "negative"}, {"name": "fresenius", "sentiment": "negative"}, {"name": "u.s. food and drug administration", "sentiment": "none"}, {"name": "ludwig burger", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "FRANKFURT (Reuters) - Fresenius ( FREG.DE ) said on Tuesday its investigation into potential breaches of U.S. Food and Drug Administration data requirements at takeover target Akorn ( AKRX.O ) was ongoing.\nFresenius headquarters in Bad Homburg near Frankfurt, Germany, February 27, 2018. REUTERS/Ralph Orlowski A Fresenius spokesman said that a legal settlement of claims stemming from inaccurate 2014 financial statements by Akorn, announced on Monday, was not related to Freseniusâ€™s own probe, which the company last month warned may result in it calling off the deal.\nReporting by Ludwig Burger; Editing by Arno Schuetze\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-27T19:43:00.000+03:00", "crawled": "2018-03-28T18:43:32.032+03:00", "highlightTitle": ""}